Acquisitions30 Dec 2024, 02:36 pm
Biocon Biologics Fulfills All Deferred Milestones Under Acquisition Agreement with Viatris
AI Summary
Biocon Biologics, a subsidiary of Biocon Ltd., has announced the fulfillment of all deferred milestones under its acquisition agreement with Viatris. This marks the complete and final remittance of considerations from Biocon Biologics towards Viatris for the acquisition. The announcement signifies the successful completion of the acquisition agreement between the two entities.
Key Highlights
- Biocon Biologics has fulfilled all deferred milestones under the acquisition agreement with Viatris.
- This is a full and final remittance of considerations from Biocon Biologics toward Viatris for the acquisition.